HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malignancies in Children with Human Immunodeficiency Virus Infection - Our Experience at Chandigarh, North India.

AbstractBackground:
With improved survival in children living with human immunodeficiency virus (HIV) infection (CLHIV), malignancies are being increasingly recognized.
Patients and methods:
Among the CLHIV registered at our institute from January 1994 to March 2015, children with malignancy were analysed in detail.
Results:
In total, 734 children affected by HIV were registered. Out of these, 11 children (9 boys, 2 girls) were diagnosed to have malignancy. Malignancy was the presenting feature of HIV infection in 4 children. High-grade non-Hodgkin lymphoma (NHL) was the most common malignancy noted in 9 of 11 (81%) children, whereas the remaining 2 children had Hodgkin's lymphoma. Survival in our cohort was 80% among children in whom chemotherapy was initiated, and overall survival was 36% (4 of 11 children).
Conclusion:
NHL was the most common malignancy in CLHIV in our cohort. Low-conditioning chemotherapy protocols along with initiation of anti-retroviral therapy resulted in improved outcomes in CLHIV with malignancy.
AuthorsDeepti Suri, Sagar Bhattad, Anju Gupta, Amita Trehan, Deepak Bansal, Arvind Rajwanshi, Ashim Das, Amit Rawat, Surjit Singh
JournalJournal of tropical pediatrics (J Trop Pediatr) Vol. 63 Issue 3 Pg. 210-216 (06 01 2017) ISSN: 1465-3664 [Electronic] England
PMID27771623 (Publication Type: Journal Article)
Copyright© The Author [2016]. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]
Topics
  • Adolescent
  • Age Distribution
  • Child
  • Cohort Studies
  • Female
  • HIV Infections (complications, diagnosis, epidemiology)
  • Humans
  • India
  • Lymphoma, AIDS-Related (diagnosis, epidemiology, pathology)
  • Lymphoma, Non-Hodgkin
  • Male
  • Medical Records
  • Neoplasms (complications, mortality)
  • Risk Factors
  • Sex Distribution
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: